Xeomin 200 unit vials

Ended Awarded

Contract number
SPE2DR26FKJ8X
Awardee
Awarding agency
Obligated
$30,017

Award facts

Contract value 100% obligated
$30,017.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $30,017 delivery order to Amerisourcebergen Drug Corp on June 22, 2026, for 200-unit vials of XEOMIN (botulinum toxin type A), with final completion due July 14, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen operates as the execution entity for DLA pharmaceutical distribution under its parent company, Cencora, Inc., and holds position on multiple DLA Troop Support Medical indefinite delivery contracts that support worldwide military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26FKJ8X?

SPE2DR26FKJ8X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 22, 2026.

How much is contract SPE2DR26FKJ8X worth?

The government has obligated $30,017 on SPE2DR26FKJ8X.

Is contract SPE2DR26FKJ8X an order under another contract?

Yes. SPE2DR26FKJ8X is a delivery order under SPE2DR25D1106, an indefinite delivery contract.

Was contract SPE2DR26FKJ8X competed?

The extent of competition for SPE2DR26FKJ8X was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award